<span class="SearchCriteria">Cluster</span> attacks usually respond within 10 minutes. There is no evidence of tachyphylaxis, rebound syndromes, or drug dependency with the use of subcutaneous sumatriptan for <span class="SearchCriteria">cluster</span> <span class="SearchCriteria">headache</span>s. <span class="SearchCriteria">Cluster</span> patients may find that their attacks can be aborted with sumatriptan SQ at smaller doses, such as 2 to 3 mg.</p>

<p>Intranasal sumatriptan 20 mg is not as effective 